Maria Vernachio Counseling, Llc - Mental Health Clinic in Beachwood, NJ

Maria Vernachio Counseling, Llc is a mental health clinic (Community/behavioral Health) in Beachwood, New Jersey. The current practice location for Maria Vernachio Counseling, Llc is 625 Atlantic City Blvd, Beachwood, New Jersey. For appointments, you can reach them via phone at (732) 737-1158. The mailing address for Maria Vernachio Counseling, Llc is 625 Atlantic City Blvd, Beachwood, New Jersey and phone number is (732) 737-1158.

Maria Vernachio Counseling, Llc is licensed to practice in New Jersey (license number 44SC01304300) and its NPI number is 1659545358. This medical practice does not participate in medicare program and thus may not accept your medicare insurance. You may check if they accept your insurance at (732) 737-1158.

Contact Information

Maria Vernachio Counseling, Llc
625 Atlantic City Blvd
Beachwood
NJ 08722-4007
(732) 737-1158
(848) 480-2833

Mental Health Clinic Profile

Full NameMaria Vernachio Counseling, Llc
SpecialityCommunity/behavioral Health
Location625 Atlantic City Blvd, Beachwood, New Jersey
Authorized Official Name and PositionMaria Vernachio (LCSW)
Authorized Official Contact7327371158
Accepts Medicare InsuranceThis clinic does not participate in Medicare Program.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Maria Vernachio Counseling, Llc
625 Atlantic City Blvd
Beachwood
NJ 08722-4007

Ph: (732) 737-1158
Maria Vernachio Counseling, Llc
625 Atlantic City Blvd
Beachwood
NJ 08722-4007

Ph: (732) 737-1158

NPI Details:

NPI Number1659545358
Provider Enumeration Date04/15/2008
Last Update Date12/22/2011

Medical Identifiers

Medical identifiers for Maria Vernachio Counseling, Llc such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1659545358NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
251S00000XCommunity/behavioral Health 44SC01304300 (New Jersey)Primary

News Archive

Telaprevir offers advantages in patients with chronic hepatitis C infection of genotype 1

The drug telaprevir has been available for treatment of chronic hepatitis C infection of genotype 1 since autumn 2011. In an early benefit assessment pursuant to the "Act on the Reform of the Market for Medicinal Products" (AMNOG), the German Institute for Quality and Efficiency in Health Care (IQWiG) examined whether telaprevir offers an added benefit compared with the present standard therapy.

First clinical study for development of SGX203 to treat pediatric Crohn's disease

Soligenix, Inc. (Soligenix or the Company), a clinical stage biopharmaceutical company focused on developing products to treat inflammatory diseases and biodefense countermeasures where there remains an unmet medical need, announced today that it has enrolled and treated all patients in the Phase 1 Study BDP-PCD-01; the first clinical study for development of SGX203 (oral beclomethasone 17,21-dipropionate or oral BDP) for the treatment of pediatric Crohn's disease.

Lecture to explain science behind modern pharmaceutical products

The science behind the creation of medicines is the subject of a lecture at the University of Greenwich's Medway Campus on Wednesday, April 13.

New tool reveals mutations that cause HIV-drug resistance

Protease inhibitor drugs are one of the major weapons in the fight against HIV, the virus that causes AIDS, but their effectiveness is limited as the virus mutates and develops resistance to the drugs over time.

Sleep strongly 'protects' negative emotional response

A recent study by sleep researchers at the University of Massachusetts Amherst is the first to suggest that a person's emotional response after witnessing an unsettling picture or traumatic event is greatly reduced if the person stays awake afterward, and that sleep strongly "protects" the negative emotional response.

Read more News

› Verified 9 days ago

Community/Behavioral Health in Beachwood, NJ

Ymca Of Greater Monmouth County
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 1675 Pinewald Rd, Beachwood, NJ 08722
Phone: 732-290-9040    Fax: 732-566-0433
Creative Life Strategies, Llc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 625 Route 9, Beachwood, NJ 08722
Phone: 732-580-6619    Fax: 732-228-7335
Emotional Healing Llc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 436 Cable Ave, Beachwood, NJ 08722
Phone: 484-808-1731    
Ymca Of Greater Monmouth County
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 901 Berkeley Ave, Beachwood, NJ 08722
Phone: 732-290-9040    Fax: 732-566-0433
Poane Counseling Services, Llc.
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 111 Admiral Ave, Beachwood, NJ 08722
Phone: 732-616-7240    
Beautiful Minds Counseling Center, Llc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 36 Maple St, Beachwood, NJ 08722
Phone: 848-448-1729    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.